col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


175 Results       Page 1

 [1] 
Wiley: Respirology
  original article Date Title Authors   All Authors
1 [GO] 2022―Sep―22 The ill winds of COVID -19: How the pandemic improved respiratory health for some Robert J. Hancox, Catherina L. Chang
2 [GO] 2022―Aug―11 Respiratory admissions before and during the COVID-19 pandemic with mediation analysis of air pollutants, mask-wearing and influenza rates Fanny Wai San Ko, Louis Ho Shing Lau, So Shan Ng, Terry Cheuk Fung Yip, Grace Lai Hung Wong, Ka Pang Chan, et al. (+2)
3 [GO] 2022―Aug―10 Pulmonary function testing during SARS-CoV -2: An ANZSRS / TSANZ position statement Brigitte M. Borg, Christian Osadnik, Keith Adam, David G. Chapman, Catherine E. Farrow, Vanda Glavas, et al. (+6)
4 [GO] 2022―May―05 Innovations during the Covid -19 pandemic to maintain delivery of care for vocal cord dysfunction ( VCD ) in a multidisciplinary team ( MDT ) clinic Joo Koh, Malcolm Baxter, Debra Phyland, Laurence Ruane, Adriana Avram, Elizabeth Leahy, et al. (+4)
5 [GO] 2022―Apr―27 Reply: Hearing the voices of Australian frontline healthcare workers during the COVID-19 pandemic Natasha Smallwood, Jaimie-Lee Maple, Karen Willis
6 [GO] 2022―Apr―13 The ongoing impact of COVID -19 pandemic restrictions on the cardio-respiratory health of New Zealanders Sarah M. Fairweather, Catherina L. Chang, Robert J. Hancox
7 [GO] 2022―Mar―25 Lessons learned from staging the Olympics during a pandemic Yoichi Nakanishi
8 [GO] 2022―Jan―20 COVID -19 infection and the broader impacts of the pandemic on healthcare workers Natasha Smallwood, Warren Harrex, Megan Rees, Karen Willis, Catherine M. Bennett
9 [GO] 2022―Jan―05 Changes to clinical education during the COVID -19 pandemic: Challenges and opportunities Mark Lavercombe
10 [GO] 2021―Dec―06 COVID-19 and critical care capacity: Can we mitigate demand? Matthew Byrne, Timothy E. Scott, Jonathan Sinclair, Nachiappan Chockalingam
11 [GO] 2021―Nov―22 Decline in mortality due to respiratory diseases in Japan during the coronavirus disease 2019 pandemic Nobuyuki Horita, Hideaki Kato, Keisuke Watanabe, Yu Hara, Nobuaki Kobayashi, Takeshi Kaneko
12 [GO] 2021―Nov―20 P5-72: Lipid involvements on inflammatory changes and clinical outcomes in patients with COVID-19
13 [GO] 2021―Nov―20 P5-89: Effectiveness of a questionnaire to screen COVID-19
14 [GO] 2021―Nov―20 P5-90: Association of persistent and delayed symptoms with pneumonia in COVID-19
15 [GO] 2021―Nov―20 P5-91: Clinical characteristics and mortality risk in patients with severe COVID-19
16 [GO] 2021―Nov―20 P5-23: Neurological complications of patients with COVID-19
17 [GO] 2021―Nov―20 P5-53: Early initiation of steroid therapy is a risk factor of treatment failure in patients with COVID-19
18 [GO] 2021―Nov―20 P5-58: Efficacy of concurrent administration of tocilizumab with corticosteroids for patients with COVID-19
19 [GO] 2021―Nov―20 P5-47: Safety and efficacy of remdesivir, baricitinib and high-dose steroid combination therapy in patients hospitalized with COVID-19
20 [GO] 2021―Nov―20 P1-26: Cytokines secreted by PC9-MET and PC9 cells may worsen COVID-19
21 [GO] 2021―Nov―20 P5-34: Long-haul COVID-19 among University of Santo Tomas hospital-health care workers following hospitalization for COVID-19 pneumonia
22 [GO] 2021―Nov―20 P6-56: One case of a patient on maintenance dialysis who concurrently suffered from both COVID-19 and a relapse of pulmonary tuberculosis
23 [GO] 2021―Nov―20 P6-58: Pneumothorax as a clinical manifestation of lung tuberculosis with co-infection COVID-19 and bacterial pneumonia
24 [GO] 2021―Nov―20 P1-86: Prone positioning treatment for COVID-19 ARDS patients with pneumomediastinum and subcutaneous emphysema during treatment of mechanical ventilation.: A two cases report
25 [GO] 2021―Nov―20 P11-6: Indices of endogenous intoxication in patients with COVID-19 associated pneumonia
26 [GO] 2021―Nov―20 P5-81: Correlation of serum ferritin level with disease severity of COVID-19 at Arifin Achmad General Hospital Riau Province
27 [GO] 2021―Nov―20 P5-82: The correlation of cycle threshold value with severity of COVID-19 at the isolation of new emerging and re-emerging infectious diseases room Arifin Achmad General Hospital Riau Province Indonesia
28 [GO] 2021―Nov―20 P1-78: Descriptive analysis of patients attending an outpatient post COVID-19 clinic in a tertiary care hospital in Sri Lanka
29 [GO] 2021―Nov―20 P5-8: Risk factors for mortality of COVID-19 confirmed cases admitted at lung center of the Philippines
30 [GO] 2021―Nov―20 P5-113: Baseline characteristics, clinical course and outcomes of COVID-19 confirmed healthcare workers in the University of Santo Tomas Hospital
31 [GO] 2021―Nov―20 P11-5: Clinical outcomes of hypoxemic, COVID-19 confirmed patients on high-flow nasal cannula (HFNC) therapy in a tertiary government hospital in Metro Manila, Philippines: A retrospective study
32 [GO] 2021―Nov―20 O19-3: The outcomes of evolving treatment regimens among COVID-19 Confirmed severe and critical cases admitted at the lung center of the Philippines
33 [GO] 2021―Nov―20 P5-98: Vitamin D deficiency as a marker of severe COVID-19 course
34 [GO] 2021―Nov―20 P5-104: Reinfection of COVID-19 critical condition in miliary tuberculosis case with multiple comorbidities
35 [GO] 2021―Nov―20 P6-44: Case report of a newly diagnosed bacteriologically confirmed pulmonary tuberculosis in a patient with COVID-19 critical infection
36 [GO] 2021―Nov―20 P5-54: Guillain-Barre syndrome-acute motor axonal neuropathy as neurologic sequela in a COVID-19 critically-ill patient: A case report
37 [GO] 2021―Nov―20 P5-77: Prognostic factors associated with death and progressiveness of COVID-19 disease at Sanglah Hospital, Denpasar
38 [GO] 2021―Nov―20 P5-30: Risk factors for hospitalization in patients with mild SARS-CoV-2 infection (COVID-19) during residential or home care
39 [GO] 2021―Nov―20 P5-42: Assessment of outcome and risk categorization of COVID-19 exposed healthcare workers using a risk assessment tool in a Tertiary Care Hospital, Sri Lanka
40 [GO] 2021―Nov―20 P5-88: Study of C reactive protein (HS-CRP) in post COVID-19 geriatric patients
41 [GO] 2021―Nov―20 P5-101: A case report of COVID-19 in an adult filipino with HIV-associated histoplasmosis
42 [GO] 2021―Nov―20 P13-2: The effect of vitamin D on the course of COVID-19 in children
43 [GO] 2021―Nov―20 P5-6: A convenient risk prediction score for COVID-19 in determining whether hospitalization should be recommended: Kanagawa admission priority assessment score (KAPAS)
44 [GO] 2021―Nov―20 P5-132: Rehabilitation interventions and tasks for patients with COVID-19 in our hospital
45 [GO] 2021―Nov―20 P5-60: Clinical and radiological features of COVID-19 in pregnant women: A case-control study
46 [GO] 2021―Nov―20 P1-74: COVID-19 in renal transplant recipients in a resource poor setting: A case series
47 [GO] 2021―Nov―20 P1-95: It runs in the family: case series of severe and critical COVID-19 in three family members
48 [GO] 2021―Nov―20 P5-74: Serial changes in clinical characteristics of COVID-19 infected patients
49 [GO] 2021―Nov―20 P16-97: Secondary organizing pneumonia following COVID-19 infection
50 [GO] 2021―Nov―20 P5-118: Clinical outcomes of diffuse alveolar damage and organising pneumonia in severe COVID-19 infection
51 [GO] 2021―Nov―20 O5-2: Factors affecting compliance to COVID-19 infection prevention and control measures and its effects on the risk of COVID-19 infection among physicians in a tertiary government hospital
52 [GO] 2021―Nov―20 P5-138: Correlation between brixia score and RTPCR-SARS-CoV-2 result of pediatric patients with suspected or confirmed COVID-19 infection seen at Chong Hua Hospital, Cebu City from March 2020 to February 2021
53 [GO] 2021―Nov―20 P1-79: Diaphragm dysfunction developed after COVID-19 infection without pneumonia
54 [GO] 2021―Nov―20 P1-24: Correlation of chest CT findings and severity of coronavirus disease (COVID-19) infections in patients admitted at Chinese General Hospital and Medical Center
55 [GO] 2021―Nov―20 P5-13: COVID-19 mobile test unit (COMBAT): A novel pharyngeal sampling platform for COVID-19 testing in Malaysia
56 [GO] 2021―Nov―20 P1-15: Chest X-ray improvement in COVID-19 moderate symptoms with remdesvir and favipiravir: A comparative study
57 [GO] 2021―Nov―20 P5-37: Community-acquired respiratory virus cases mimic COVID-19 on lung computed tomography
58 [GO] 2021―Nov―20 P6-5: Impact of COVID-19 on tuberculosis in Japan; A national database analysis
59 [GO] 2021―Nov―20 P16-60: Post COVID-19 organizing pneumonia treated with mycophenolate mofetil
60 [GO] 2021―Nov―20 P1-51: Status of palliative care in respiratory disease before and after COVID-19 outbreak
61 [GO] 2021―Nov―20 P3-6: A clinical analysis of PAP (pulmonary alveolar proteinosis) s diagnosed with difficulty in the COVID-19 pandemic
62 [GO] 2021―Nov―20 P12-8: New style for bronchoscopy to prevent infection under COVID-19 pandemic
63 [GO] 2021―Nov―20 P8-180: Growth inhibitory effects of chemotherapeutics drugs in EGFR-mutated PC9 cells during the COVID-19 pandemic
64 [GO] 2021―Nov―20 P1-8: Impact on inhalation adherence of asthma and COPD patients during the COVID-19 pandemic
65 [GO] 2021―Nov―20 P16-95: High incidence of MPO-ANCA positive interstitial pneumonia during the COVID-19 pandemic
66 [GO] 2021―Nov―20 O17-1: Asthma status during COVID-19 pandemic
67 [GO] 2021―Nov―20 P4-10: Burnout among healthcare workers during COVID-19 pandemic in Aceh, Indonesia
68 [GO] 2021―Nov―20 P5-92: Respiratory viruses during COVID-19 pandemic in Okinawa, Japan
69 [GO] 2021―Nov―20 P5-33: Impacts of the COVID-19 pandemic on hospitalizations for pneumonia in Brazil
70 [GO] 2021―Nov―20 P4-25: The dynamics of the quality of life of healthy people amid the COVID-19 pandemic when soy and pumpkin products are included in the diet
71 [GO] 2021―Nov―20 P5-109: A fatal case of multiple mycotic pulmonary artery aneurysms due to Aspergillus terreus in a post COVID-19 patient
72 [GO] 2021―Nov―20 P1-2: Correlations in physical symptoms, blood biochemical findings, and chest ct images in an early phase of COVID-19 patient
73 [GO] 2021―Nov―20 P11-11: Bilateral iliopsoas hematomas in a severe COVID-19 patient treated with unfractionated heparin: A case report and review of literature
74 [GO] 2021―Nov―20 P12-12: Bronchoscopy with n-acetylcysteine lavage in a COVID-19 patient with massive grade IV inhalation injury
75 [GO] 2021―Nov―20 P5-46: Myocardial injury association with severity of disease in hospitalized COVID-19 patients
76 [GO] 2021―Nov―20 P5-108: The association between awake prone positioning and mortality in COVID-19 patients
77 [GO] 2021―Nov―20 P1-13: Effect of bromhexine among COVID-19 patients - A meta-analysis
78 [GO] 2021―Nov―20 P5-20: The prevalence of comorbid respiratory disease among COVID-19 patients, and mortality during the first wave in Japan: A nationwide survey by the Japanese Respiratory Society
79 [GO] 2021―Nov―20 P5-127: Clinical characteristics of SARS-CoV-2 infected (COVID-19) patients and mutant viral strains in rural area of Japan
80 [GO] 2021―Nov―20 P5-27: Evaluation of serum interferon lambda 3 in hospitalized COVID-19 patients as a biomarker to predict the severity
81 [GO] 2021―Nov―20 P5-83: The correlation between cycle threshold polymerase chain reaction COVID-19 with the extent of chest X-ray abnormalities and D-dimer in COVID-19 patients at Arifin Achmad General Hospital Riau Province
82 [GO] 2021―Nov―20 P5-135: D-dimer as a predictor severity and mortality in hospitalized COVID-19 patients at Saiful Anwar General Hospital Malang
83 [GO] 2021―Nov―20 P1-9: Predictive factor of high-flow nasal oxygen failure in COVID-19 patients at tertiary hospital in Jakarta
84 [GO] 2021―Nov―20 P5-136: The correlation between leucocyte, lymphocyte, thrombocyte, and sofa score on the severity of COVID-19 patients hospitalized in the PINERE Ward of Saiful Anwar Hospital
85 [GO] 2021―Nov―20 O6-4: Treatment outcomes of COVID-19 patients in Hong Kong's first designated infection control centre and the impact of emergent SARS-CoV-2 mutant strains from imported cases
86 [GO] 2021―Nov―20 P1-36: Multicenter study elucidating factors associated with sequelae of discharged COVID-19 patients in Japan
87 [GO] 2021―Nov―20 P5-68: The use of an institutionalized respiratory protocol as a decision-making tool improved outcomes among severe and critically-ill COVID-19 patients in Perpetual Succour Hospital
88 [GO] 2021―Nov―20 O8-5: Prevalence of acute myocardial injury among COVID-19 patients in Persahabatan Hospital, Jakarta
89 [GO] 2021―Nov―20 P5-145: COVID-19: Performance of oseltamivir and isoprinosine in neutrophil-to-lymphocyte ratio improvement from confirmed COVID-19 patients in Saiful Anwar General Hospital, Malang
90 [GO] 2021―Nov―20 P5-36: Association of C-reactive protein (CRP), serum ferritin, and patient outcome in COVID-19 patients in tertiary referral hospital
91 [GO] 2021―Nov―20 P5-105: Relationship of total thrombocyte, lymphocyte account and PLR (platelet lymphocyte ratio) to severity degree of COVID-19 patients in ward
92 [GO] 2021―Nov―20 P11-14: Blood gas analysis and alveolar-arterial gradient as predictor of mortality confirmed COVID-19 patients outcome in Tertiary Referral Hospital
93 [GO] 2021―Nov―20 P5-112: The relationship of chest X-ray in COVID-19 patients towards disease severity at Arifin Achmad Regional General Hospital, Riau Province
94 [GO] 2021―Nov―20 P5-76: Prolonged viral clearance in COVID-19 patients treated with tocilizumab
95 [GO] 2021―Nov―20 P5-142: A case series on corticosteroid use in COVID-19 patients who suffered from chronic lung disease
96 [GO] 2021―Nov―20 P5-150: COVID-19 patients with a late diagnosis of HIV
97 [GO] 2021―Nov―20 P5-70: Effectiveness of favipiravir in COVID-19 patients with multiple (≥2) or less (<2) comorbidities: A real word experience from India
98 [GO] 2021―Nov―20 P5-106: Japanese, multicenter, phase II trial of combination therapy with favipiravir and methylprednisolone for COVID-19 patients with non-critical respiratory failure: the J-critical trial
99 [GO] 2021―Nov―20 P5-79: Clinical comparison of the first wave and the later waves in COVID-19 patients with pneumonia
100 [GO] 2021―Nov―20 P5-64: Therapeutic effectiveness & safety of favipiravir in COVID-19 patients with risk factors for mortality: Clinical practice experience from India
101 [GO] 2021―Nov―20 P5-19: Spontaneous pneumothorax in Indonesian COVID-19 patients: A retrospective case series
102 [GO] 2021―Nov―20 P5-71: Rapidly progressive honeycombing in a spontaneously breathing patient with COVID-19 pneumonia
103 [GO] 2021―Nov―20 P5-62: Evaluation of lung cell populations in severe COVID-19 pneumonia
104 [GO] 2021―Nov―20 P5-87: Time course of oxygen demand in patients with COVID-19 pneumonia
105 [GO] 2021―Nov―20 P5-85: Staged treatment of middle lobe lung gangrene using the vacuum-assisted closure therapy in a patient with severe COVID-19 pneumonia
106 [GO] 2021―Nov―20 P5-152: Familial ciclesonide-responsive cases of COVID-19 pneumonia
107 [GO] 2021―Nov―20 P5-144: Infected pneumatoceles complicating the course of COVID-19 pneumonia
108 [GO] 2021―Nov―20 P1-77: Long-COVID syndrome associated with COVID-19 pneumonia
109 [GO] 2021―Nov―20 P5-57: Comparison of chest HRCT findings between COVID-19 pneumonia and anti-MDA5 antibody-positive interstitial pneumonia by computer-based quantitative CT image analysis
110 [GO] 2021―Nov―20 P5-14: An age-matched comparison between COVID-19 pneumonia and pneumococcal pneumonia cases
111 [GO] 2021―Nov―20 P5-15: A case of recurred exacerbations and remissions of COVID-19 pneumonia in a patient with b-cell lymphoma undergoing chemotherapy
112 [GO] 2021―Nov―20 P5-43: A case of hyperpyrexia of hypothalamic origin associated with severe COVID-19 pneumonia in pregnancy
113 [GO] 2021―Nov―20 P5-26: Validity of PIRO-score as an assessment tool for mortality risk of COVID-19 pneumonia in World Citi Medical Center. A retrospective observational cohort study
114 [GO] 2021―Nov―20 P11-13: Diffuse pulmonary hemorrhage, a catastrophic outcome of a 57-year-old venezuelan, with COVID-19 pneumonia, who developed multiple thrombosis and aman-variant GBS
115 [GO] 2021―Nov―20 P1-83: A case report of primi 30 weeks of pregnancy with COVID-19 pneumonia with dengue fever
116 [GO] 2021―Nov―20 P5-97: High-dose methylprednisolone in combination with tocilizumab in hospitalized patients with critical COVID-19 pneumonia: A case series
117 [GO] 2021―Nov―20 P5-67: Predictors of mortality in severe COVID-19 pneumonia: An interim analysis from a single Tertiary Care Centre in Central Sri Lanka
118 [GO] 2021―Nov―20 P5-80: A case report of pneumothorax associated with COVID-19 pneumoniae
119 [GO] 2021―Nov―20 P5-143: Post-corona virus disease 2019 (COVID-19) pneumothorax
120 [GO] 2021―Nov―20 P15-16: Modified dose thrombolysis in a COVID-19 related massive acute pulmonary embolism: A case report
121 [GO] 2021―Nov―20 P5-125: Abrupt cessation of systemic corticosteroid in coronavirus disease 19 (COVID-19) related secondary organizing pneumonia resulted in a rebound
122 [GO] 2021―Nov―20 O10-1: Community-led tuberculosis and COVID-19 risk communication in the Vietnamese migrant population in Japan
123 [GO] 2021―Nov―20 P5-28: Correlation of serum interleukin-6 level and COVID-19 severity on hospital admission and survival
124 [GO] 2021―Nov―20 P14-9: Lung function analysis of COVID-19 survivors in dr. Zainoel Abidin Hospital Banda Aceh, Indonesia
125 [GO] 2021―Nov―20 P5-122: A case of secondary organizing pneumonia caused by relapse of inflammation after COVID-19 treatment with systemic corticosteroid and tocilizumab
126 [GO] 2021―Nov―20 O8-4: Determination of antibody titers of filipino healthcare workers after COVID-19 vaccination (Sinovac and Astrazenica) - A preliminary report
127 [GO] 2021―Nov―20 O7-1: Structural differentiation of the spike glycoprotein from SARS-CoV-2 COVID-19 variants of concern compared to other human-infecting coronaviruses: A computational study with clinical implications
128 [GO] 2021―Nov―20 P11-2: Clinical profiles and respiratory system mechanics of mechanically ventilated patients with COVID-19 versus non-COVID-19-associated ARDS
129 [GO] 2021―Nov―20 P5-31: High prevalence of silent hypoxia among patients with COVID-19 warrants screening for oxyhemoglobin desaturation among patients with fever, cough or dyspnea
130 [GO] 2021―Nov―20 P5-40: An autopsy case of COVID-19 with disseminated mucormycosis
131 [GO] 2021―Nov―20 P7-61: Management & caring for patients of COPD with COVID-19: A current perspective
132 [GO] 2021―Nov―20 P5-121: Inhaled beclomethasone in the treatment of early COVID-19: A placebo-controlled, randomized trial
133 [GO] 2021―Nov―20 O8-3: The effectiveness of the combined use of remdesivir and regdanvimab (CT-P59) in patients with severe COVID-19: A single center retrospective study
134 [GO] 2021―Nov―20 P11-7: Issues related to ECMO management in critically ill patients with COVID-19: A systematic review and meta-analysis
135 [GO] 2021―Nov―20 P5-111: SARS-CoV-2 PCR and antigen positivity continued for 3 months after treatment for severe COVID-19: Case report
136 [GO] 2021―Nov―20 P5-51: Organizing pneumonia post COVID-19: Outcomes of treatment with corticosteroids in the outpatient setting
137 [GO] 2021―Nov―20 P5-93: Therapeutic effectiveness and tolerability of favipiravir in mild COVID-19: Real world experience from India
138 [GO] 2021―Nov―20 P5-32: Investigation of exacerbation factors in patients with coronavirus disease 2019
139 [GO] 2021―Nov―20 P6-50: Primary multidrug-resistant tuberculosis in coronavirus disease 2019
140 [GO] 2021―Nov―20 P5-94: The usefulness of a combination of age, body mass index, and blood urea nitrogen as prognostic factors in predicting oxygen requirements in patients with coronavirus disease 2019
141 [GO] 2021―Nov―20 P5-56: Predictive model for the development of critical coronavirus disease 2019 in Japan
142 [GO] 2021―Nov―20 P8-37: Delayed visit and treatment of lung cancer during the coronavirus disease 2019 pandemic in Japan
143 [GO] 2021―Nov―20 P1-34: Passive microwave radiometry as an early screening diagnostic of pneumonia due to coronavirus infection 2019 lung complications in Kyrgyzstan
144 [GO] 2021―Nov―20 P5-55: What kind of disease has developed in a teenager against the background of a new coronavirus infection? Is it Kawasaki's or Reye's syndrome?
145 [GO] 2021―Nov―20 P1-94: The challenges of patients that with home using long term oxygen therapy under coronavirus pandemic
146 [GO] 2021―Nov―20 P5-149: Investigation of antibody level by the presence or absence of side effects after the new coronavirus vaccine
147 [GO] 2021―Nov―20 P13-1: Chest X-ray findings of coronavirus-19 disease in patients age 0 to 18 years old admitted at Chong Hua Hospital from March 2020 to February 2021
148 [GO] 2021―Nov―20 O6-3: Bioinformatics analysis of high-throughput sequencing to identify key genes and signaling pathways in vero E6 cells infected by SARS-CoV-2
149 [GO] 2021―Nov―20 P6-12: The cruel dual; SARS-CoV-2 and tuberculosis co-infection, the Sri Lankan experience
150 [GO] 2021―Nov―20 P5-24: Severity and clinical outcome of SARS-CoV-2 infected patients following COVID vaccination - An observational study in Bangladesh
151 [GO] 2021―Nov―20 P5-123: The clinical features and outcomes of discharged SARS-CoV-2 patients: A prospective cohort study
152 [GO] 2021―Nov―20 P2-40: Expression of the SARS-CoV-2 receptor ACE2 and proinflammatory cytokines induced by the periodontopathic bacterium Fusobacterium nucleatum in human respiratory epithelial cells
153 [GO] 2021―Nov―20 P5-41: Rapid and simultaneous identification of multiple mutations by the Novaplex TM SARS-CoV-2 variants assay kits
154 [GO] 2021―Nov―20 P10-24: Successful extubation in a phenobarbital overdose attempted suicide in a non-ideal set-up at the time of COVID 19 pandemic
155 [GO] 2021―Nov―20 P5-11: Vaccine-induced immune thrombotic thrombocytopenia (VITT) after ChAdOx1 nCoV-19 vaccination
156 [GO] 2021―Nov―10 Clinical differentiation of severe acute respiratory syndrome coronavirus 2 pneumonia using the Japanese guidelines Naoyuki Miyashita, Yasushi Nakamori, Makoto Ogata, Naoki Fukuda, Akihisa Yamura, Yoshihisa Ishiura, Shosaku Nomura
157 [GO] 2021―Sep―01 Mental health among healthcare workers during the COVID -19 pandemic Natasha Smallwood, Karen Willis
158 [GO] 2021―Aug―30 Air pollution and the pandemic: Long-term PM 2.5 exposure and disease severity in COVID -19 patients Angelico Mendy, Xiao Wu, Jason L. Keller, Cecily S. Fassler, Senu Apewokin, Tesfaye B. Mersha, et al. (+2)
159 [GO] 2021―Aug―24 Decline in respiratory and cardiac admissions during the COVID -19 pandemic: What is the role of common respiratory virus infections? Chloe I. Bloom, Sebastian L. Johnston
160 [GO] 2021―Aug―13 Risk of severe acute respiratory syndrome coronavirus 2 ( SARS-CoV -2) transmission during bronchoscopy in the intensive care unit Biplab K. Saha, Praveen Chenna
161 [GO] 2021―Aug―08 Impact of COVID -19 pandemic restrictions on the cardio-respiratory health of New Zealanders Sarah M. Fairweather, Catherina L. Chang, Christopher J Mansell, Eskandarain Shafuddin, Robert J. Hancox
162 [GO] 2021―Jun―28 The 1918 influenza and COVID -19 pandemics: The effect of age on outcomes Paul T. King, Sarah L. Londrigan
163 [GO] 2021―May―27 Pathophysiology of infection with SARS-CoV -2- What is known and what remains a mystery Siddharth Sridhar, John Nicholls
164 [GO] 2021―Mar―08 Provision of essential bronchoscopy during COVID -19 pandemic Waheed Shah, Orla O'Carroll, Michael P. Keane, Cormac McCarthy
165 [GO] 2021―Mar―02 Letter from Canada: A pandemic that has humbled us? Stephan F. van Eeden
166 [GO] 2020―Dec―16 Delayed access to lung cancer screening and treatment during the COVID -19 pandemic: Are we headed for a lung cancer pandemic? Tracy L. Leong
167 [GO] 2020―Oct―14 Attenuating COVID-19 infection and inflammation: Lessons from asthma Philip G. Bardin, Sebastian L. Johnston
168 [GO] 2020―Sep―22 Respiratory management of adult patients with acute respiratory distress syndrome due to COVID-19 Priyanka Makkar, Stephen M Pastores
169 [GO] 2020―Sep―21 Pulmonary rehabilitation in COVID -19 pandemic era: The need for a revised approach Ajay Prashad Gautam, Ross Arena, Snehil Dixit, Audrey Borghi-Silva
170 [GO] 2020―Aug―18 Letter from Singapore: The clinical and research response to COVID-19 Sanjay H. Chotirmall, Lin-Fa Wang, John A. Abisheganaden
171 [GO] 2020―Jul―07 Universal public mask wear during COVID -19 pandemic: Rationale, design and acceptability Christopher Liu, Rawya Diab, Hasan Naveed, Victor Leung
172 [GO] 2020―Jun―17 Targeting the interleukin-17 pathway to prevent acute respiratory distress syndrome associated with SARS-CoV -2 infection Tomas Raul Wiche Salinas, Boyang Zheng, Jean-Pierre Routy, Petronela Ancuta
173 [GO] 2020―May―21 The role of SARS-CoV -2 antibodies in COVID -19: Healing in most, harm at times Martyn A. French, Yuben Moodley
174 [GO] 2020―May―14 Safe performance of diagnostic bronchoscopy/ EBUS during the SARS-CoV -2 pandemic Daniel P. Steinfort, Felix J.F. Herth, Louis B. Irving, Phan T. Nguyen
175 [GO] 2020―Apr―11 Summarizing societal guidelines regarding bronchoscopy during the COVID-19 pandemic Robert J. Lentz, Henri Colt
 [1] 

175 Results       Page 1



[de][en]

Last change 2022―Feb―03 17:06:14 UTC

© Daten-Quadrat 2022       Done in 0.015 sec